HemaSphere (Aug 2023)
S191: PIVOTAL PHASE 2 MONUMENTAL-1 RESULTS OF TALQUETAMAB (TAL), A GPRC5DXCD3 BISPECIFIC ANTIBODY (BSAB), FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)
- Cyrille Touzeau,
- Carolina Schinke,
- Monique Minnema,
- Niels W.C.J. van de Donk,
- Paula Rodríguez-Otero,
- Maria-Victoria Mateos,
- Leo Rasche,
- Jing Christine Ye,
- Deeksha Vishwamitra,
- Xuewen MA,
- Xiang Qin,
- Michela Campagna,
- Tara Masterson,
- Brandi Hilder,
- Jaszianne Tolbert,
- Thomas Renaud,
- Jenna Goldberg,
- Christoph Heuck,
- Ajai Chari
Affiliations
- Cyrille Touzeau
- 1 Centre Hospitalier Universitaire de Nantes, Nantes, France
- Carolina Schinke
- 2 Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, United States
- Monique Minnema
- 3 University Medical Center Utrecht, Utrecht, The Netherlands
- Niels W.C.J. van de Donk
- 4 Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
- Paula Rodríguez-Otero
- 5 Clínica Universidad de Navarra, CIMA, CIBERONC, IDISNA, Pamplona, Spain
- Maria-Victoria Mateos
- 6 University Hospital of Salamanca/IBSAL/CIC/CIBERONC, Salamanca, United States
- Leo Rasche
- 7 University Hospital of Würzburg, Würzburg, Germany
- Jing Christine Ye
- 8 University of Michigan, Rogel Cancer Center, Ann Arbor, United States
- Deeksha Vishwamitra
- 9 Janssen Research & Development, Spring House, United States
- Xuewen MA
- 9 Janssen Research & Development, Spring House, United States
- Xiang Qin
- 9 Janssen Research & Development, Spring House, United States
- Michela Campagna
- 10 Janssen Research & Development, Madrid, Spain
- Tara Masterson
- 9 Janssen Research & Development, Spring House, United States
- Brandi Hilder
- 9 Janssen Research & Development, Spring House, United States
- Jaszianne Tolbert
- 9 Janssen Research & Development, Spring House, United States
- Thomas Renaud
- 11 Janssen Research & Development, Raritan, United States
- Jenna Goldberg
- 12 Janssen Research & Development, Raritan, NJ, United States at the time that the work was performed
- Christoph Heuck
- 9 Janssen Research & Development, Spring House, United States
- Ajai Chari
- 13 Mount Sinai School of Medicine, New York, United States
- DOI
- https://doi.org/10.1097/01.HS9.0000967676.59550.94
- Journal volume & issue
-
Vol. 7
p. e5955094
Abstract
No abstracts available.